Willow Biosciences Inc Cash Flow Conversion Efficiency

Latest as of March 2025: 0.055x

Willow Biosciences Inc cash flow conversion efficiency. Based on the latest financial reports, Willow Biosciences Inc (WLLW) has a cash flow conversion efficiency ratio of 0.055x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-38.00K ≈ $-27.49K USD) by net assets (CA$-690.00K ≈ $-499.14K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Willow Biosciences Inc (2000–2024)

Cash flow conversion efficiency of Willow Biosciences Inc from 2000 to 2024. This chart illustrates how Willow Biosciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Willow Biosciences Inc share price for real-time trading data and today's change.

Willow Biosciences Inc Cash Flow Conversion Ratio Explained

Willow Biosciences Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Willow Biosciences Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Willow Biosciences Inc ranked by their cash flow conversion efficiency. Also see WLLW market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Athena Resources Ltd AU:AHN	-0.044x
Protektor S.A. WAR:PRT	-0.007x
MEKICS Co Ltd KQ:058110	-0.012x
Nippon Active Value Fund Plc LSE:NAVF	0.005x
Youxin Technology Ltd Class A Ordinary shares NASDAQ:YAAS	-0.155x
HIGH QUALITY FOOD F:L24	N/A
Me Group International PLC LSE:MEGP	0.180x
Better Choice Company Inc NYSE MKT:BTTR	0.048x

Annual Cash Flow Conversion Efficiency for Willow Biosciences Inc (2000–2024)

The table below shows the annual cash flow conversion efficiency of Willow Biosciences Inc from 2000 to 2024. Review Willow Biosciences Inc (WLLW) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$-505.00K ≈ $-365.31K	CA$-3.72 Million ≈ $-2.69 Million	7.372x	+331.97%
2023-12-31	CA$3.44 Million ≈ $2.49 Million	CA$-10.92 Million ≈ $-7.90 Million	-3.178x	-275.40%
2022-12-31	CA$16.37 Million ≈ $11.84 Million	CA$-13.86 Million ≈ $-10.03 Million	-0.847x	-37.86%
2021-12-31	CA$29.68 Million ≈ $21.47 Million	CA$-18.23 Million ≈ $-13.19 Million	-0.614x	-102.69%
2020-12-31	CA$-559.00K ≈ $-404.37K	CA$-12.78 Million ≈ $-9.24 Million	22.862x	+5592.30%
2019-12-31	CA$22.01 Million ≈ $15.92 Million	CA$-9.16 Million ≈ $-6.63 Million	-0.416x	+73.93%
2018-12-31	CA$835.03K ≈ $604.05K	CA$-1.33 Million ≈ $-964.33K	-1.596x	-143.05%
2017-12-31	CA$-145.01K ≈ $-104.90K	CA$-537.68K ≈ $-388.95K	3.708x	+10.99%
2016-12-31	CA$-383.33K ≈ $-277.30K	CA$-1.28 Million ≈ $-926.41K	3.341x	+876.08%
2015-12-31	CA$1.01 Million ≈ $728.19K	CA$-433.34K ≈ $-313.47K	-0.430x	+3.17%
2014-12-31	CA$1.38 Million ≈ $999.85K	CA$-614.45K ≈ $-444.48K	-0.445x	+30.69%
2013-12-31	CA$1.44 Million ≈ $1.04 Million	CA$-921.19K ≈ $-666.37K	-0.641x	-502.05%
2012-12-31	CA$901.49K ≈ $652.12K	CA$-96.04K ≈ $-69.48K	-0.107x	+52.32%
2011-12-31	CA$2.53 Million ≈ $1.83 Million	CA$-564.70K ≈ $-408.49K	-0.223x	+9.07%
2010-12-31	CA$3.52 Million ≈ $2.55 Million	CA$-865.76K ≈ $-626.28K	-0.246x	-44.84%
2009-12-31	CA$5.24 Million ≈ $3.79 Million	CA$-889.16K ≈ $-643.20K	-0.170x	+36.10%
2008-12-31	CA$3.47 Million ≈ $2.51 Million	CA$-922.61K ≈ $-667.40K	-0.266x	+39.98%
2007-12-31	CA$2.50 Million ≈ $1.81 Million	CA$-1.11 Million ≈ $-799.41K	-0.442x	-104.59%
2006-12-31	CA$-21.98K ≈ $-15.90K	CA$-211.79K ≈ $-153.21K	9.634x	+1974.10%
2005-12-31	CA$-109.44K ≈ $-79.17K	CA$-50.84K ≈ $-36.77K	0.465x	+121.24%
2004-12-31	CA$-714.97K ≈ $-517.20K	CA$-150.11K ≈ $-108.59K	0.210x	+37667.14%
2002-12-31	CA$-674.55K ≈ $-487.96K	CA$-375.00 ≈ $-271.27	0.001x	+219.56%
2001-12-31	CA$-604.35K ≈ $-437.18K	CA$281.00 ≈ $203.27	0.000x	-100.19%
2000-12-31	CA$-441.04K ≈ $-319.04K	CA$-105.17K ≈ $-76.08K	0.238x	--

About Willow Biosciences Inc

TO:WLLW Canada Drug Manufacturers - Specialty & Generic

Market Cap

$18.10 Million

CA$25.02 Million CAD

Market Cap Rank

#28468 Global

#1242 in Canada

Share Price

CA$0.17

Change (1 day)

+0.00%

52-Week Range

CA$0.17 - CA$0.17

All Time High

CA$2.08